Actinium Pharmaceuticals, Inc. (Delaware) Common Stock financial statements
Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.
Filed statements
| USD; millions except EPS | Jun 2026Filed 07/08/2026 | Mar 2026Filed 07/08/2026 | Sep 2025Filed 14/11/2025 | Jun 2025Filed 07/08/2026 | Mar 2025Filed 07/08/2026 | Sep 2024Filed 14/11/2025 | Jun 2024Filed 14/11/2025 | Mar 2024Filed 14/11/2025 |
|---|---|---|---|---|---|---|---|---|
| $35 | — | $0.1 | — | — | — | — | — | |
| $28 | −$5.5 | −$5.1 | −$6.9 | −$16 | −$12 | −$11 | −$8.7 | |
| $0.89 | −$0.18 | −$0.16 | −$0.22 | −$0.51 | −$0.37 | −$0.38 | −$0.31 | |
| 31 | 31 | 31 | 31 | 31 | 31 | 30 | 28 |
Trend